Answers are grounded in this paper and cite their sources.
Article Abstract Click to enlarge page Patients with major depressive disorder (MDD) who have responded to or remitted from antidepressant treatment frequently have persistent residual symptoms (eg, fatigue, sleep problems, cognitive symptoms) that interfere with their functioning and quality of life and significantly increase the risk of relapse. Clinicians need to systematically evaluate for all depressive symptoms at baseline, so that some are not missed and the individual patient's symptoms can be tracked across all phases of treatment. Developing a list of target problems that the patient would like to see improve is a helpful tool in this process.
No takes yet. Share an insight, caveat, or question.
Zajecka et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: